San Diego-based mostly Viking Therapeutics marked by itself as a serious competitor while in the weight loss drug current market in February soon after revealing promising information from the mid-stage demo of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when offered as a weekly injection As well